Neogap värvar tungt namn inom cellterapi

Bioteknikbolaget Neogap Therapeutics fyller på styrelsen med expertis inom cellterapi i form av professor Jonas Mattsson.

Samuel Lagercrantz: We are currently seeing medical breakthroughs in these areas

Samuel Lagercrantz, Editor in Chief of Life Science Sweden, lists three medical fields in which we are currently seeing major breakthroughs and two fields in wh...

New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Copenhagen (2026)

Specific proposals and targets top the universities’ desired priorities

What are the universities’ expectations for the update of the national life science strategy? Life Science Sweden posed the question to representatives from Kar...

ZEISS Metrology Expert Tips

New video series provides valuable expert knowledge.

Lucy Robertshaw: Artificial intelligence – is this really going to transform a patient’s life?

In a column Lucy Robertshaw reflects on how AI and new regulations will affect healthcare, innovation and the lives of future patients.

Wusson Accelerator AB

Bioscience – Groundbreaking Research & Diagnostics: Gothenburg (2026)

Novo Nordisk kapar banden med Hims & Hers efter Wegovy-strid

Novo Nordisk avslutar samarbetet med Hims & Hers Health. Anledningen är oro kring företagets försäljning och marknadsföring av viktläkemedlet Wegovy.

The new ZEISS Celldiscoverer 7 has been launched

Adaptable automation for advanced workflows.

SGS Fimko Ltd.

Aurevia

CTC Clinical Trial Consultants AB

She is CSL Behring's new Nordic General Manager

Since the beginning of january, Helena Bragd is the new Nordic General Manager for the biotech company CSL Behring and CEO of CSL Behring AB.

EU har nått läkemedelsuppgörelse – ”Inte tillräckligt”

Efter fleråriga förhandlingar har EU nått en preliminär uppgörelse om ett omfattande läkemedelspaket. Uppgörelsen innebär bland annat att kommissionens omstridd...

AI upptäcker tumörsjukdom – via röstinspelning

En kort röstinspelning tillsammans med ansiktsbilder – i bägge fallen analyserade med en AI-algoritm – kan göra det möjligt att upptäcka den sällsynta tumörsjuk...

Learn from Speakers from Leading MedTech Companies

Watch the recordings from ZEISS Quality Innovation Days whenever it suits you.

Cleveland Clinic: Kirurgi gav fler långsiktiga fördelar än GLP-1-läkemedel

Metabol kirurgi minskade riskerna för död, hjärtsjukdom, njursvikt och ögonskador mer än GLP-1-läkemedel under en tioårsperiod. Det enligt en ny studie från Cle...

Moderna develops mRNA vaccine against norovirus

A highly anticipated vaccine is in late clinical evaluation and could be ready for approval within a couple of years. The target is the norovirus, often called ...

Xbrane enters licensing agreement with Indian generics giant

Swedish biosimilar developer Xbrane Biopharma and the Indian company Intas Pharmaceuticals have entered into a license and co-development agreement.

Mercodia AB

This years Nobel prize in medicine – “Changed the understanding of how genes are controlled”

This year’s Nobel Prize in Physiology or Medicine goes to the discovery that small RNA molecules, known as microRNAs, control how genes are regulated. Understan...

Rapid developments in AI – “All stakeholders are struggling to understand it”

Artificial intelligence is being discussed more and more, and developments in the field are moving rapidly. As the Swedish Medical Products Agency testifies, ke...

JMP Statistical Discovery